In the latest development in Sanofi’s Philippines dengue vaccine scandal, the nation’s Department of Health has demanded that the French pharma firm pay out a full refund of the 3 billion Philippine pesos the government paid to immunise its citizens “because the purported or reported or claimed protection [of Dengvaxia] wasn’t felt and wasn’t there.”
Image caption:
Image Credit: Sanofi
